Kathleen M Dungan

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi The effect of diabetes on hospital readmissions
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio 43210, USA
    J Diabetes Sci Technol 6:1045-52. 2012
  2. ncbi Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs
    Kathleen M Dungan
    Ohio State University Medical Center, Columbus, OH, USA
    Diabetes Res Clin Pract 96:e66-9. 2012
  3. ncbi Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio, USA
    J Diabetes Sci Technol 6:884-91. 2012
  4. ncbi Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin
    K Dungan
    Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH, USA
    Diabetes Obes Metab 13:1130-5. 2011
  5. ncbi Comparison of 3 algorithms for Basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery
    Kathleen Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio, USA
    Endocr Pract 17:753-8. 2011
  6. ncbi The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure
    Kathleen M Dungan
    Division of Endocrinology, Department of Internal Medicine, Diabetes and Metabolism, Ohio State University, Columbus, OH 43210 1296, USA
    Diabetes Metab Res Rev 27:85-93. 2011
  7. ncbi Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University, Columbus, OH, USA
    Endocr Pract 16:945-51. 2010
  8. ncbi Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP)
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University School of Medicine, Columbus, OH, USA
    Diabetes Metab Res Rev 25:558-65. 2009
  9. ncbi Stress hyperglycaemia
    Kathleen M Dungan
    The Ohio State University, Columbus, OH 43210 1296, USA
    Lancet 373:1798-807. 2009
  10. ncbi 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions
    Kathleen M Dungan
    Ohio State University, 4th Floor McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, USA
    Expert Rev Mol Diagn 8:9-19. 2008

Detail Information

Publications15

  1. ncbi The effect of diabetes on hospital readmissions
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio 43210, USA
    J Diabetes Sci Technol 6:1045-52. 2012
    ..Prospective interventional studies targeting interventions for improving glycemic control are needed to determine whether glycemic control impacts readmission rates...
  2. ncbi Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs
    Kathleen M Dungan
    Ohio State University Medical Center, Columbus, OH, USA
    Diabetes Res Clin Pract 96:e66-9. 2012
    ..8%) LM25-treated patients and 72 (63.7%) glargine-treated patients (p=0.238) with 1,5AGā‰„median, suggesting, 1,5AG may offer therapeutic insight when starting insulin therapy...
  3. ncbi Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio, USA
    J Diabetes Sci Technol 6:884-91. 2012
    ..The accuracy of continuous glucose monitoring (CGM) in non-critically ill hospitalized patients with heart failure or severe hyperglycemia (SH) is unknown...
  4. ncbi Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin
    K Dungan
    Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH, USA
    Diabetes Obes Metab 13:1130-5. 2011
    ..To determine whether an insulin algorithm could be used in a similar manner in the setting of diabetes and stress hyperglycaemia following cessation of intravenous (IV) insulin after cardiac surgery...
  5. ncbi Comparison of 3 algorithms for Basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery
    Kathleen Dungan
    Division of Endocrinology, Diabetes, and Metabolism, Ohio State University, Columbus, Ohio, USA
    Endocr Pract 17:753-8. 2011
    ....
  6. ncbi The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure
    Kathleen M Dungan
    Division of Endocrinology, Department of Internal Medicine, Diabetes and Metabolism, Ohio State University, Columbus, OH 43210 1296, USA
    Diabetes Metab Res Rev 27:85-93. 2011
    ..diabetes and CHF are common comorbidities in hospitalized patients but the relationship between glycaemic control, glycaemic variability, and mortality in patients with both conditions is unclear...
  7. ncbi Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University, Columbus, OH, USA
    Endocr Pract 16:945-51. 2010
    ..To determine the relationship between inpatient glycemic control and hospital readmission in patients with congestive heart failure (CHF)...
  8. ncbi Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP)
    Kathleen M Dungan
    Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University School of Medicine, Columbus, OH, USA
    Diabetes Metab Res Rev 25:558-65. 2009
    ..Islet neogenesis associated protein (INGAP) has beta cell regenerating effects in experimental models...
  9. ncbi Stress hyperglycaemia
    Kathleen M Dungan
    The Ohio State University, Columbus, OH 43210 1296, USA
    Lancet 373:1798-807. 2009
    ..We describe classification of stress hyperglycaemia, mechanisms of harm, and management strategies...
  10. ncbi 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions
    Kathleen M Dungan
    Ohio State University, 4th Floor McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, USA
    Expert Rev Mol Diagn 8:9-19. 2008
    ....
  11. ncbi A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes
    Kathleen M Dungan
    Ohio State University School of Medicine, Columbus, OH, USA
    Curr Med Res Opin 23:2689-95. 2007
    ..Patients with diabetes often do not reach recommended lipid targets. This may be in part due to the difficulty of obtaining fasting measurements...
  12. ncbi 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes
    Kathleen M Dungan
    Division of Endocrinology, University of North Carolina School of Medicine, Durham, NC, USA
    Diabetes Care 29:1214-9. 2006
    ..1,5-AG may be useful as a complementary marker to A1C to assess glycemic control in moderately controlled patients with diabetes...
  13. ncbi Clinical outcomes associated with referral-based continuous glucose monitoring using a central standardized interpretation strategy
    Anthony Miele
    The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    Diabetes Technol Ther 14:765-71. 2012
    ..A referral-based system using a centralized standard interpretation completed by a specialist could highlight the most pertinent information and provide recommendations...
  14. ncbi The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes
    Nora Alghothani
    Department of Internal Medicine, Mount Carmel Health System, Columbus, Ohio, USA
    Diabetes Technol Ther 13:1085-9. 2011
    ..Glycemic variability (GV) is associated with hypoglycemia and possibly diabetes-related outcomes. We hypothesized that GV and glucose excursion risk may predict counterregulatory (CR) hormone responses to hypoglycemia...
  15. ncbi Expression and biological effect of urodele fibroblast growth factor 1: relationship to limb regeneration
    Kathleen M Dungan
    Department of Molecular Genetics, The Ohio State University, Columbus, Ohio 43210, USA
    J Exp Zool 292:540-54. 2002
    ....